Oasmia

Our vision is to improve the treatment of severe diseases in order to provide benefits for both patients and society as a whole.

Read more

Press releases

October 14, 2019 Regulatory press release
Notice of extraordinary general meeting in Oasmia Pharmaceutical AB
October 14, 2019 Regulatory press release
The Board of Directors in Oasmia proposes a rights issue of approximately SEK 400 million
September 26, 2019 Regulatory press release
Annual General Meeting in Oasmia Pharmaceutical AB on September 26, 2019

All press releases

Financial reports

Calendar

December 20, 2019 Interim Report May – October 2019
March 27, 2020 Interim Report May 2019 – January 2020
June 18, 2020 Year-end Report May 2019 – April 2020

The Share

Follow the share

We uses cookies in order to optimize your use of our website. Read more about cookies.

OK